Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Myriad Genetics, Memorial Sloan Kettering Partner to Study MRD Testing in Breast Cancer 360dx.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 360dx.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ NewStem Ltd., a bio-platform company, today announced a collaboration with the MSK Innovation Hub to further optimize and validate NewStem s.
The Israeli startup called this collaboration a necessary step toward commercializing its CE-marked NewStem Software Diagnostic Device for reducing oncology drug resistance.
MSK News: His Cancer Has Spread Three Times, but It's Not Stopping Garth Atchley | Memorial Sloan Kettering Cancer Center mskcc.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mskcc.org Daily Mail and Mail on Sunday newspapers.